Moving away from BMI: a new era of diagnostic criteria in obesity.

IF 2.8 Q3 ENDOCRINOLOGY & METABOLISM
Rhea Sibal, G Balamurugan, Yitka Graham, Kamal Mahawar
{"title":"Moving away from BMI: a new era of diagnostic criteria in obesity.","authors":"Rhea Sibal, G Balamurugan, Yitka Graham, Kamal Mahawar","doi":"10.1080/17446651.2025.2537160","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Obesity is a chronic, progressive, and heterogeneous disease defined by excess adiposity that impairs health. While Body Mass Index (BMI) remains the most used diagnostic tool, it is increasingly regarded as an inadequate measure of obesity. BMI does not account for inter-individual, including inter-ethnic variation in fat distribution, body composition and metabolic health. These limitations highlight the need for a more nuanced and clinically robust diagnostic framework in obesity.</p><p><strong>Areas covered: </strong>This article examines the shortcomings of BMI as a diagnostic tool and explores a range of alternative metrics, including anthropometric indices, clinical staging systems and direct assessments of adiposity and metabolic dysfunction, drawing on a narrative review of literature from 1950 to 2025 using PubMed. We also review recent international expert consensus statements and updated clinical guidelines from leading health organizations.</p><p><strong>Expert opinion: </strong>Research progress in obesity diagnostics is expected to drive a shift away from BMI toward more clinically useful approaches. Future clinical practice could adopt more personalized management strategies, to guide prevention, diagnosis, and intervention in obesity care.</p>","PeriodicalId":12107,"journal":{"name":"Expert Review of Endocrinology & Metabolism","volume":" ","pages":"403-413"},"PeriodicalIF":2.8000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Endocrinology & Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17446651.2025.2537160","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/29 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Obesity is a chronic, progressive, and heterogeneous disease defined by excess adiposity that impairs health. While Body Mass Index (BMI) remains the most used diagnostic tool, it is increasingly regarded as an inadequate measure of obesity. BMI does not account for inter-individual, including inter-ethnic variation in fat distribution, body composition and metabolic health. These limitations highlight the need for a more nuanced and clinically robust diagnostic framework in obesity.

Areas covered: This article examines the shortcomings of BMI as a diagnostic tool and explores a range of alternative metrics, including anthropometric indices, clinical staging systems and direct assessments of adiposity and metabolic dysfunction, drawing on a narrative review of literature from 1950 to 2025 using PubMed. We also review recent international expert consensus statements and updated clinical guidelines from leading health organizations.

Expert opinion: Research progress in obesity diagnostics is expected to drive a shift away from BMI toward more clinically useful approaches. Future clinical practice could adopt more personalized management strategies, to guide prevention, diagnosis, and intervention in obesity care.

远离BMI:肥胖症诊断标准的新时代。
肥胖症是一种慢性、进行性、异质性疾病,其特征是过度肥胖损害健康。虽然身体质量指数(BMI)仍然是最常用的诊断工具,但越来越多的人认为它不足以衡量肥胖。BMI不能解释个体间的差异,包括种族间脂肪分布、身体组成和代谢健康的差异。这些局限性突出了需要一个更细致和临床可靠的肥胖诊断框架。涵盖领域:本文通过对PubMed 1950年至2025年的文献进行叙述性回顾,研究了BMI作为诊断工具的缺点,并探索了一系列替代指标,包括人体测量指数、临床分期系统和肥胖和代谢功能障碍的直接评估。我们还审查了最近的国际专家共识声明和主要卫生组织的最新临床指南。专家意见:肥胖诊断的研究进展有望推动从BMI转向更临床有用的方法。未来的临床实践可以采用更加个性化的管理策略,指导肥胖护理的预防、诊断和干预。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Expert Review of Endocrinology & Metabolism
Expert Review of Endocrinology & Metabolism ENDOCRINOLOGY & METABOLISM-
CiteScore
4.80
自引率
0.00%
发文量
44
期刊介绍: Implicated in a plethora of regulatory dysfunctions involving growth and development, metabolism, electrolyte balances and reproduction, endocrine disruption is one of the highest priority research topics in the world. As a result, we are now in a position to better detect, characterize and overcome the damage mediated by adverse interaction with the endocrine system. Expert Review of Endocrinology and Metabolism (ISSN 1744-6651), provides extensive coverage of state-of-the-art research and clinical advancements in the field of endocrine control and metabolism, with a focus on screening, prevention, diagnostics, existing and novel therapeutics, as well as related molecular genetics, pathophysiology and epidemiology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信